ClinicalTrials.gg
Sign In

Lymphoma, Follicular clinical trials

The registry lists 1,891 studies for Lymphoma, Follicular across more than 10 countries. 289 are recruiting or about to start. 520 of them are mainly about Lymphoma, Follicular (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-13.

ClinicalTrials.gov finds 2,119 studies for Lymphoma, Follicular. How that becomes 1,891 here

This page counts the studies the registry files under Lymphoma, Follicular, and those it files under no condition that list Lymphoma, Follicularthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 2,119Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −70List Lymphoma, Follicular as a condition, but the registry did not file them under itMost often written as “Follicular Lymphoma Grade 3B” (9), “Recurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma” (9), and “Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma” (9). The registry filed them under other conditions only, most often Lymphoma, Large B-Cell, Diffuse (55) and Lymphoma, B-Cell (9).
  3. −158Match it another way43 name it in the title, 12 in a keyword, and 103 by a synonym or other text the search reads.
  4. 1,891The count on this page16 of them list Lymphoma, Follicular in their own words; the registry filed them under no condition.

Get an email when these change. Save the Lymphoma, Follicular studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
1,002
Terminated
243
Recruiting
225
Status unknown
142
Active, not recruiting
134
Withdrawn
77

Phase

Phase 2
726
Phase 1
613
Phase 3
222
Phase 4
32
Early Phase 1
19

Where

United States
1,185
France
179
Italy
148
China
147
Germany
143
United Kingdom
138

Who runs them

National Cancer Institute (NCI) (111) · Fred Hutchinson Cancer Center (59) · Memorial Sloan Kettering Cancer Center (38) · City of Hope Medical Center (37) · M.D. Anderson Cancer Center (34) · Masonic Cancer Center, University of Minnesota (29) · Mayo Clinic (28) · Case Comprehensive Cancer Center (25)

What is being tested here

Drugs under test in Lymphoma, Follicular studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Rituximab1036189
Zanubrutinib9113
Lenalidomide8751
Obinutuzumab7127
Mosunetuzumab7216
Epcoritamab7213
Fludarabine4579
Cyclophosphamide3794
Odronextamab325
Surovatamig324

Drug classes tested here Tyrosine kinase inhibitors (TKIs) 21 open · Alkylating agents 7 open · Antimetabolites 5 open · Immune checkpoint inhibitors 4 open · Antibody-drug conjugates (ADCs) 4 open

Coming up

41phase 3 studies under way
121studies finish main data collection within a year4 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 225 Lymphoma, Follicular studies recruiting now, 158 (70%) set no upper age limit and 39 (17%) stop at 75 or younger. 33 (15%) take children under 18. 7 (3%) are for women only and 0 (0%) for men only; 24 (11%) take healthy volunteers.

Recruiting studies that take each age, of 225
AgeWomenMen
1024 (11%)23 (10%)
18203 (90%)198 (88%)
30206 (92%)200 (89%)
40204 (91%)198 (88%)
50206 (92%)202 (90%)
65209 (93%)205 (91%)
75197 (88%)193 (86%)
85177 (79%)173 (77%)

Across all 1,891 studies, recruiting or not: 24% stop at 75 or younger and 14% at 65; 18% take children; 1% are for women only and <1% for men only; 7% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Lymphoma, Follicular studies take

Of 199 phase 2 interventional studies under Lymphoma, Follicular, half reached primary completion within 57 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 151 mo30–80 · 173 studies44 mo21–71 · 84 studies57 mo38–99 · 89 studies
Phase 1/273 mo50–114 · 88 studies68 mo51–103 · 43 studies75 mo50–114 · 45 studies
Phase 257 mo31–97 · 199 studies29 mo21–52 · 48 studies67 mo40–110 · 151 studies
Phase 363 mo36–106 · 80 studies49 mo25–86 · 45 studies76 mo54–116 · 35 studies
Interventional, no phase27 mo13–47 · 165 studies—26 mo9–47 · 141 studies
Observational49 mo34–120 · 81 studies—43 mo27–165 · 55 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 15, 2026.

Started recruiting2

Results posted5

Stopped1

Newly registered4

Studies

Recruiting first, then most recently updated. Showing 50 of 1,891. Browse all 1,891 → or search them.